PLAU and neoplasm: Many adverse events can occur after chemotherapy, some of them are harmful and can even be fatal: it is thus necessary to develop some tests (GES for instance) or identify tumor markers (uPA-PAI-1, for example) to improve and refine the selection of patients for whom chemotherapy could be avoided.